Susanne Roehrig

In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939—an oral, direct Factor Xa inhibitor

Elisabeth Perzborn, Andreas Wilmen, Jens Pohlmann et al. · Journal of Thrombosis and Haemostasis · 2005 · 583 citations · Full text

Molecular Pharmacology, Thrombosis, Vivo Studies +9

Discovery of the Novel Antithrombotic Agent 5-Chloro-<i>N</i>-({(5<i>S</i>)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939):  An Oral, Direct Factor Xa Inhibitor

Susanne Roehrig, Alexander Straub, Jens Pohlmann et al. · Journal of Medicinal Chemistry · 2005 · 429 citations · Full text

Pharmacotherapy, Chemical Biology, Pharmaceutical Chemistry +17

Pharmacological profile of asundexian, a novel, orally bioavailable inhibitor of factor XIa

Stefan Heitmeier, Mayken Visser, Adrian Tersteegen et al. · Journal of Thrombosis and Haemostasis · 2022 · 81 citations · Full text

Synthesis and transformations of d-glucuronic and l-iduronic acid glycals

Peter Schell, Hernán A. Orgueira, Susanne Roehrig et al. · Tetrahedron Letters · 2001 · 46 citations

Bioorganic Chemistry, Biochemistry, Natural Sciences +5

Selective formation of C-2 azidodeoxy-d-glucose derivatives from d-glucal precursors using the azidonitration reaction

Peter H. Seeberger, Susanne Roehrig, Peter Schell et al. · Carbohydrate Research · 2000 · 36 citations

Bioorganic Chemistry, Engineering, Biochemistry +9